Cardiovascular disease risk in Korean patients with systemic lupus erythematosus compared to diabetes mellitus and the general population

被引:0
|
作者
Han, Jung-Yong [1 ,2 ]
Cho, Soo-Kyung [1 ,2 ]
Jeon, Yena [3 ]
Kang, Gaeun [3 ]
Jung, Sun-Young [4 ]
Jang, Eun Jin [5 ]
Sung, Yoon-Kyoung [1 ,2 ]
机构
[1] Hanyang Univ Hosp Rheumat Dis, Dept Rheumatol, Seoul 04763, South Korea
[2] Hanyang Univ, Inst Rheumatol Res, Seoul, South Korea
[3] Kyungpook Natl Univ, Dept Stat, Daegu, South Korea
[4] Chung Ang Univ, Coll Pharm, Seoul, South Korea
[5] Andong Natl Univ, Dept Informat Stat, Andong, South Korea
来源
SCIENTIFIC REPORTS | 2025年 / 15卷 / 01期
基金
新加坡国家研究基金会;
关键词
Systemic lupus erythematosus; Cardiovascular disease; Diabetes mellitus; MYOCARDIAL-INFARCTION; MORTALITY; EVENTS; STROKE; COHORT; WOMEN;
D O I
10.1038/s41598-025-87740-y
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
To evaluate the incidence and risk of cardiovascular disease (CVD) among Korean patients with systemic lupus erythematosus (SLE) comparing them to diabetes patients and the general population. This nationwide cohort study focused on incident SLE patients aged over 40 years, matched with diabetes patients and the general population (1:4:4 ratio). CVD was defined as ischaemic heart disease, ischaemic stroke, and cardiac arrest. Incidence rate and incidence rate ratio (IRR) of CVD were calculated using generalised estimating equation models. The Fine-Gray model assessed risk factors for CVD in both SLE and diabetes patients. The study included 4272 incident SLE patients, 17,003 diabetes patients, and 17,088 from the general population. SLE patients had higher CVD risk compared to the general population, with adjusted IRRs of 1.99 for overall CVD. Diabetes patients showed increased CVD risk, but to a lesser extent, with an IRR of 1.39. SLE patients aged 40-59 years displayed a significantly elevated CVD risk. Advanced age, male gender, and current use of glucocorticoids, immunosuppressive, and anti-platelet agents were associated with increased CVD risk in SLE patients. SLE patients have a higher risk of CVD compared to the general population, more so than diabetes patients.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Risk factors for cardiovascular disease in systemic lupus erythematosus
    Svenungsson, E
    Jensen-Urstad, K
    Heimbürger, M
    Silveira, A
    Hamsten, A
    de Faire, U
    Witztum, JL
    Frostegård, J
    CIRCULATION, 2001, 104 (16) : 1887 - 1893
  • [22] Risk Factors in Cardiovascular Disease in Systemic Lupus Erythematosus
    Angelica Sinicato, Nailu
    da Silva Cardoso, Priscila Aparecida
    Appenzeller, Simone
    CURRENT CARDIOLOGY REVIEWS, 2013, 9 (01) : 15 - 19
  • [23] CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Camilo Diaz-Coronado, Juan
    Herrera-Uribe, Sebastian
    Hernandez, Deicy
    Betancur-Vasquez, Laura
    Lacouture-Fierro, Jorge
    Gonzalez-Hurtado, Daniel
    Gonzalez-Arango, Juanita
    Uribe-Arango, Laura
    Fernanda Saavedra-Chacon, Maria
    Monsalve-Yepes, Santiago
    Guerra-Zarama, Sebastian
    David Serna-Giraldo, Jose
    David Lopez-Lopez, Juan
    Barbosa-Arana, Julian
    Camila Soto-Osorio, Maria
    Pineda-Tamayo, Ricardo A.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S38 - S38
  • [24] Insulin Resistance and Diabetes Mellitus in Patients with Systemic Lupus Erythematosus
    Garcia-Carrasco, Mario
    Mendoza-Pinto, Claudia
    Munguia-Realpozo, Pamela
    Etchegaray-Morales, Ivet
    Velez-Pelcastre, Sandra Karina
    Mendez-Martinez, Socorro
    Zamora-Ginez, Irma
    de Lara, Luis Guillermo Vazquez
    Galvez-Romero, Jose Luis
    Escamilla-Marquez, Marco
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2023, 23 (04) : 503 - 514
  • [25] The cardiovascular risk associates in systemic lupus erythematosus patients
    Dima, A.
    Balanescu, P.
    Delcea, C.
    Balanescu, E.
    Badea, C.
    Buzea, A.
    Ionescu, R.
    Baicus, C.
    Dan, G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (03) : S80 - S80
  • [26] Assessing the cardiovascular risk in patients with systemic lupus erythematosus
    Arnaud, L.
    Mathian, A.
    Bruckert, E.
    Amoura, Z.
    REVUE DE MEDECINE INTERNE, 2014, 35 (11): : 723 - 729
  • [27] CONTRIBUTION OF FRAMINGHAM RISK FACTORS TO CARDIOVASCULAR DISEASE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Bessant, R.
    Rahman, A.
    Heath, J.
    Isenberg, D. A.
    RHEUMATOLOGY, 2002, 41 : 108 - 108
  • [28] Clinical characteristics and risk factors of cardiovascular disease in systemic lupus erythematosus patients
    Liao, Qiumei
    Zhong, Yeping
    Cheng, Yalin
    Li, Xiuxiu
    HEART AND VESSELS, 2024,
  • [29] Management of cardiovascular disease in patients with systemic lupus erythematosus
    Piranavan, Paramarjan
    Perl, Andras
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (13) : 1617 - 1627
  • [30] Is Cardiovascular Risk and Mortality in Rheumatoid Arthritis Compared to Diabetes Mellitus and the General Population Overestimated?
    Logstrup, Brian B.
    Ellingsen, Torkell
    Pedersen, Alma B.
    Darvalics, Bianka B.
    Olesen, Kevin K.
    Botker, Hans Erik
    Maeng, Michael
    CIRCULATION, 2019, 140